José Barbé

José Barbé

Auto-generated profile, based on publicly available information

José Barbé

Clinical Pharmacology Service, Fundació Institut Català de Farmacologia, Hospital Universitari Vall d'Hebron, Department of Pharmacology, Therapeutics and Toxicology, Universitat Autònoma de Barcelona, Passeig Vall d'Hebron 119-129, 08035, Barcelona, Spain

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 April 2015 in BMC Geriatrics
Verified
Journal Article
Open access
PDF file
ASAntonio San-José
Antonio San-José
AAAntònia Agustí
Antònia Agustí
XVXavier Vidal
Xavier Vidal
FFFrancesc Formiga
Francesc Formiga
MGMercedes Gómez-Hernández
Mercedes Gómez-Hernández
OPon behalf of Potentially Inappropriate Prescription in Older Patients in Spain (PIPOPS) Investigators’ project
on behalf of Potentially Inappropriate Prescription in Older Patients in Spain (PIPOPS) Investigators’ project
Scientific evidence on treatments of chronic diseases in patients 85 years old or older is very limited, as is available information on inappropriate prescription (IP) and its associated factors. The study aimed to describe medicine prescription, potentially inappropriate medicines (PIM) and potentially prescribing omissions (PPO) and their associated factors on this population. In the context of an observational, prospective and multicentric study carried out in elderly patients admitted to seven Spanish hospitals for a year, a sub-analysis of those aged 85 years and over was performed. To assess PIMs, the Beers and STOPP criteria were used, and to assess PPOs, the START and the ACOVE-3 criteria were used. To assess factors associated with IP, a multivariate logistic regression analysis was performed. Patients were selected randomly every week on consecutive days from the hospitalization lists. A total of 336 patients were included in the sub-analysis with a median (Q1-Q3) age of 88 (86–90) years. The median medicines taken during the month prior to admission was 10 (7–13). Forty-seven point two per cent of patients had at least one Beers-listed PIM, 63.3% at least one STOPP-listed PIM, 53.6% at least one START-listed PPO, and 59.4% at least one ACOVE-3-listed PPO. Use of benzodiazepines in patients who are prone to falls (18.3%) and omission of calcium and vitamin D supplements in patients with osteoporosis (13.3%) were the most common PIM and PPO, respectively. The main factor associated with the Beers-listed and the STOPP-listed PIM was consumption of 10 or more medicines (OR = 5.7, 95% CI 1.8-17.9 and OR = 13.4, 95% CI 4.0-44.0, respectively). The main factors associated with the START-listed PPO was a non-community dwelling origin (OR 2.3, 95% CI 1.0-5.0), and multimorbidity (OR1.8, 95% CI 1.0-3.1). Prescribed medicines and PIM and PPO prevalence were high among patients 85 years and over. Benzodiazepine use in those who are prone to falls and omission of calcium and vitamin D in those with osteoporosis were the most frequent PIM and PPO, respectively. Factors associated with PIM and PPO differed with polypharmacy being the most important factor associated with PIM.

5 March 2016 in European Journal of Clinical Pharmacology
Verified
Journal Article
Closed access
PDF file
OPon behalf of Potentially Inappropriate Prescription in Older Patients in Spain (PIPOPS) Investigators’ project
on behalf of Potentially Inappropriate Prescription in Older Patients in Spain (PIPOPS) Investigators’ project
XVXavier Vidal
Xavier Vidal
AAAntònia Agustí
Antònia Agustí
AFAntonio Vallano Ferraz
Antonio Vallano Ferraz
FFFrancesc Formiga
Francesc Formiga
ASAntonio San-José
Antonio San-José